Identification of conformational neutralization sites on the fusion protein of mumps virus

Journal of General Virology

Volumn 96, Issue 5, 2015, Pages 982-990

  Šantak, Maja ^a   Örvell, Claes ^b   Gulija, Tanja Košutić ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; HYBRID PROTEIN; MONOCLONAL ANTIBODY; MUMPS VACCINE; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN; VIRUS RNA; EPITOPE; NEUTRALIZING ANTIBODY; VIRUS ANTIBODY; VIRUS FUSION PROTEIN;

ANIMAL CELL; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ARTICLE; CONFORMATIONAL TRANSITION; GLYCOSYLATION; HEMAGGLUTINATION; HEMAGGLUTINATION INHIBITION TEST; IN VITRO STUDY; MOUSE; MUMPS VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONFORMATION; VACCINATION; VACCINE FAILURE; VERO CELL LINE; VIRUS NEUTRALIZATION; VIRUS STRAIN; ANIMAL; BAGG ALBINO MOUSE; DNA SEQUENCE; GENETICS; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; MOLECULAR GENETICS; TREATMENT FAILURE;

MUMPS VIRUS;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; EPITOPES, B-LYMPHOCYTE; GLYCOSYLATION; HUMANS; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; MUMPS VACCINE; MUMPS VIRUS; SEQUENCE ANALYSIS, DNA; TREATMENT FAILURE; VIRAL FUSION PROTEINS;

EID: 84930149268     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.000059     Document Type: Article

References (34)

1. Arnold, K., Bordoli, L., Kopp, J. & Schwede, T. (2006). The SWISSMODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics 22, 195–201.
2. Biasini, M., Bienert, S., Waterhouse, A., Arnold, K., Studer, G., Schmidt, T., Kiefer, F., Cassarino, T. G., Bertoni, M. & other authors (2014). SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information. Nucleic Acids Res 42 (Web Server issue), W252–W258.
3. Bordoli, L., Kiefer, F., Arnold, K., Benkert, P., Battey, J. & Schwede, T. (2009). Protein structure homology modeling using SWISS-MODEL workspace. Nat Protoc 4, 1–13.
4. Bose, S., Heath, C. M., Shah, P. A., Alayyoubi, M., Jardetzky, T. S. & Lamb, R. A. (2013). Mutations in the parainfluenza virus 5 fusion protein reveal domains important for fusion triggering and metastability. J Virol 87, 13520–13531.
5. Chang, A. & Dutch, R. E. (2012). Paramyxovirus fusion and entry: multiple paths to a common end. Viruses 4, 613–636.
6. Chomczynski, P. & Sacchi, N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162, 156–159.
7. Cohen, B. J., Audet, S., Andrews, N., Beeler, J. & WHO working group on measles plaque reduction neutralization test (2007). Plaque reduction neutralization test for measles antibodies: Description of a standardised laboratory method for use in immunogenicity studies of aerosol vaccination. Vaccine 26, 59–66.
8. Cseke, G., Wright, D. W., Tollefson, S. J., Johnson, J. E., Crowe, J. E., Jr & Williams, J. V. (2007). Human metapneumovirus fusion protein vaccines that are immunogenic and protective in cotton rats. J Virol 81, 698–707.
9. Cusi, M. G., Fischer, S., Sedlmeier, R., Valassina, M., Valensin, P. E., Donati, M. & Neubert, W. J. (2001). Localization of a new neutralizing epitope on the mumps virus hemagglutinin-neuraminidase protein. Virus Res 74, 133–137.
10. Dayan, G. H. & Rubin, S. (2008). Mumps outbreaks in vaccinated populations: are available mumps vaccines effective enough to prevent outbreaks? Clin Infect Dis 47, 1458–1467.
11. De St Groth, S. F. & Scheidegger, D. (1980). Production of monoclonal antibodies: strategy and tactics. J Immunol Methods 35, 1–21.
12. Forcic, D., Kosutić-Gulija, T., Santak, M., Jug, R., Ivancic-Jelecki, J., Markusic, M. & Mazuran, R. (2010). Comparisons of mumps virus potency estimates obtained by 50% cell culture infective dose assay and plaque assay. Vaccine 28, 1887–1892.
13. Homan, E. J. & Bremel, R. D. (2014). Are cases of mumps in vaccinated patients attributable to mismatches in both vaccine T-cell and B-cell epitopes?. Hum Vaccin Immunother 10, 290–300.
14. Houard, S., Varsanyi, T. M., Milican, F., Norrby, E. & Bollen, A. (1995). Protection of hamsters against experimental mumps virus (MuV) infection by antibodies raised against the MuV surface glycoproteins expressed from recombinant vaccinia virus vectors. J Gen Virol 76, 421–423.
15. Johansen, P. G., Marshall, R. D. & Neuberger, A. (1961). Carbohydrates in protein. 3. The preparation and some of the properties of a glycopeptide from hen’s-egg albumin. Biochem J 78, 518–527.
16. Kövamees, J., Rydbeck, R., Örvell, C. & Norrby, E. (1990). Hemagglutinin-neuraminidase (HN) amino acid alterations in neutralization escape mutants of Kilham mumps virus. Virus Res 17, 119–129.
17. Lamb, R. A., Paterson, R. G. & Jardetzky, T. S. (2006). Paramyxovirus membrane fusion: lessons from the F and HN atomic structures. Virology 344, 30–37.
18. Mahy, B. W. J. & Kangro, H. O. (1995). Haemagglutination. In Virology methods manuals, pp. 41–43. Edited by B.W.J. Mahy & H.O. Kangro. London, UK: Academic Press.
19. Malley, R., DeVincenzo, J., Ramilo, O., Dennehy, P. H., Meissner, H. C., Gruber, W. C., Sanchez, P. J., Jafri, H., Balsley, J. & other authors (1998). Reduction of respiratory syncytial virus (RSV) in tracheal aspirates in intubated infants by use of humanized monoclonal antibody to RSV F protein. J Infect Dis 178, 1555–1561.
20. Merz, D. C., Scheid, A. & Choppin, P. W. (1980). Importance of antibodies to the fusion glycoprotein of paramyxoviruses in the prevention of spread of infection. J Exp Med 151, 275–288.
21. Norrby, E., Utter, G., Örvell, C. & Appel, M. J. (1986). Protection against canine distemper virus in dogs after immunization with isolated fusion protein. J Virol 58, 536–541.
22. Örvell, C. (1978). Structural polypeptides of mumps virus. J Gen Virol 41, 527–539.
23. Örvell, C. (1984). The reactions of monoclonal antibodies with structural proteins of mumps virus. J Immunol 132, 2622–2629.
24. Örvell, C. & Grandien, M. (1982). The effects of monoclonal antibodies on biologic activities of structural proteins of Sendai virus. J Immunol 129, 2779–2787.
25. Örvell, C., Alsheikhly, A. R., Kalantari, M. & Johansson, B. (1997). Characterization of genotype-specific epitopes of the HN protein of mumps virus. J Gen Virol 78, 3187–3193.
26. Paterson, R. G., Lamb, R. A., Moss, B. & Murphy, B. R. (1987). Comparison of the relative roles of the F and HN surface glycoproteins of the paramyxovirus simian virus 5 in inducing protective immunity. J Virol 61, 1972–1977.
27. Rubin, S. A., Link, M. A., Sauder, C. J., Zhang, C., Ngo, L., Rima, B. K. & Duprex, W. P. (2012). Recent mumps outbreaks in vaccinated populations: no evidence of immune escape. J Virol 86, 615–620.
28. Šantak, M., Kosutić-Gulija, T., Tesović, G., Ljubin-Sternak, S., Gjenero-Margan, I., Betica-Radić, L. & Forcić, D. (2006). Mumps virus strains isolated in Croatia in 1998 and 2005: Genotyping and putative antigenic relatedness to vaccine strains. J Med Virol 78, 638–643.
29. Sˇ antak, M., Lang-Balija, M., Ivancic-Jelecki, J., Košutić -Gulija, T., Ljubin-Sternak, S. & Forcic, D. (2013). Antigenic differences between vaccine and circulating wild-type mumps viruses decreases neutralization capacity of vaccine-induced antibodies. Epidemiol Infect 141, 1298–1309.
30. Tecle, T., Johansson, B., Yun, Z. & Örvell, C. (2000). Antigenic and genetic characterization of the fusion (F) protein of mumps virus strains. Arch Virol 145, 1199–1210.
31. Togashi, T., Örvell, C., Vartdal, F. & Norrby, E. (1981). Production of antibodies against measles virions by use of the mouse hybridoma technique. Arch Virol 67, 149–157.
32. Toyoda, T., Gotoh, B., Sakaguchi, T., Kida, H. & Nagai, Y. (1988). Identification of amino acids relevant to three antigenic determinants on the fusion protein of Newcastle disease virus that are involved in fusion inhibition and neutralization. J Virol 62, 4427–4430.
33. Wolinsky, J. S., Waxham, M. N. & Server, A. C. (1985). Protective effects of glycoprotein-specific monoclonal antibodies on the course of experimental mumps virus meningoencephalitis. J Virol 53, 727–734.
34. Yin, H. S., Wen, X., Paterson, R. G., Lamb, R. A. & Jardetzky, T. S. (2006). Structure of the parainfluenza virus 5 F protein in its metastable, prefusion conformation. Nature 439, 38–44.